References

Biasucci DG, Pittiruti M, Taddei A Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study. J Vasc Access. 2018; 19:(2)119-124 https://doi.org/10.5301/jva.5000797

Cordovani D, Cooper RM. A prospective trial on a new sutureless securement device for central venous catheters. Can J Anaesth. 2013; 60:(5)504-505 https://doi.org/10.1007/s12630-013-9897-7

Dolcino A, Salsano A, Dato A Potential role of a subcutaneously anchored securement device in preventing dislodgment of tunneled-cuffed central venous devices in pediatric patients. J Vasc Access. 2017; 18:(6)540-545 https://doi.org/10.5301/jva.5000780

Egan GM, Siskin GP, Weinmann R, Galloway MM. A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system. J Infus Nurs. 2013; 36:(3)181-188 https://doi.org/10.1097/NAN.0b013e3182893690

Egan Sansivero G. What's new in vascular access devices and technology?. Br J Nurs. 2012; 21:S16-S20 https://doi.org/10.12968/bjon.2012.21.Sup1.S4

Emoli A, Cappuccio S, Marche B, Musarò A, Scoppettuolo G, Pittiruti M The ISP (Safe Insertion of PICCs) protocol: a bundle of 8 recommendations to minimize the complications related to the peripherally inserted central venous catheters (PICC). Assist Inferm Ric. 2014; 33:(2)82-89 https://doi.org/10.1702/1539.16813

Hughes ME. Reducing PICC migrations and improving patient outcomes. Br J Nurs. 2014; 23:S12-S18 https://doi.org/10.12968/bjon.2014.23.Sup1.S12

Goossens GA, Grumiaux N, Janssens C SecurAstaP trial: securement with SecurAcath versus StatLock for peripherally inserted central catheters, a randomised open trial. BMJ Open. 2018; 8:(2) https://doi.org/10.1136/bmjopen-2017-016058

Scoppettuolo G, Dolcetti L, Emoli A, La Greca A, Biasucci DG, Pittiruti M. Further benefits of cyanoacrylate glue for central venous catheterisation. Anaesthesia. 2015; 70:(6) https://doi.org/10.1111/anae.13105

Zerla PA, Canelli A, Cerne L Evaluating safety, efficacy, and cost-effectiveness of PICC securement by subcutaneously anchored stabilization device. J Vasc Access. 2017; 18:(3)238-242 https://doi.org/10.5301/jva.5000655

Clinical experience of a subcutaneously anchored sutureless system for securing central venous catheters

24 January 2019
Research
02 January 2019
Volume 28 · Issue 2

Abstract

This article reports the results of three prospective clinical studies conducted in a university hospital regarding the efficacy, safety and cost effectiveness of a subcutaneously anchored sutureless system for securing central venous catheters. The results were favourable to the adoption of such a device, and the analysis of the data allowed the authors to define those categories of patients where the device should have the most benefit: neonates, children, non-compliant older patients with cognitive difficulties, patients with skin abnormalities that may reduce the effectiveness of a skin-adhesive sutureless securement system, patients who are candidates for having a peripherally inserted central catheter (PICC) in place for more than 8 weeks, and any other category of patients with a recognised high risk of catheter dislodgement.

Aspecific device for subcutaneously anchored securement (SAS) of central venous catheters (CVC) was introduced into clinical practice only a few years ago. In the authors' 1500-bed university hospital, clinicians have considered the use of such a device for the purpose of reducing or eliminating the clinical occurrence of catheter dislodgement, an often-neglected complication. In the authors' experience, CVC dislodgement is only partially prevented by current securement strategies: adoption of semipermeable transparent dressings (Tegaderm, 3M; IV 3000, Smith & Nephew); application of cyanoacrylate glue (Hystoacryl, BBraun) on the exit site; consistent use of sutureless devices, either adhesive to the skin (StatLock, BD; Grip-Lok, Zefon International; WingGuard, Centurion Medical Products) or integrated in the transparent dressing (SorbaShield, Centurion). In some patient populations within the authors' hospital (such as in children), partial or total dislodgement of the catheter is the most frequent reason for losing venous access (far more frequent than infection or venous thrombosis or lumen occlusion).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

Register
Or continue by

Signing in with your registered email address

Sutureless securement
Central venous catheters
Peripherally inserted central catheter
Subcutaneously anchored securement
Stabilisation device